PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
11-Jun-2020 Valmet to supply automation to a gas clean-up system at Viridor’s site in Scotland, UK Valmet
11-Jun-2020 First adjuvanted quadrivalent influenza vaccine receives EU approval Intended for medical, pharmaceutical industry and business media Seqirus
11-Jun-2020 Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phase 3 DOLOMITES Study of Anemia in Non-Dialysis-Dependent Adult Patients with Chronic Kidney Disease Astellas Pharma Inc
11-Jun-2020 G42 and ONT Co-Develop Ultra-Scalable Solution for COVID-19 Detection Group 42
11-Jun-2020 Genmab Announces European Marketing Authorization for the Subcutaneous Formulation of DARZALEX® (daratumumab) for the Treatment of Patients with Multiple Myeloma Genmab
11-Jun-2020 NHS Confederation chief executive to step down NHS Confederation
11-Jun-2020 Intravacc partners with Wageningen Bioveterinary Research and Utrecht University to develop an intranasal COVID-19 vaccine Intravacc
11-Jun-2020 Anti-TNF therapies could treat patients with COVID-19-related acute respiratory distress, says GlobalData GlobalData Press Office
11-Jun-2020 LUNAC Therapeutics selects XenoGesis as strategic drug discovery partner XenoGesis Ltd
11-Jun-2020 VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertibleCAR-T(TM) cell therapy Astellas Pharma Inc.
11-Jun-2020 NHS App Integrates eConsult for Online Consultations eConsult
11-Jun-2020 Annual General Meeting Statement Ergomed plc
11-Jun-2020 Vertex Announces European Commission Approval for KALYDECO® (ivacaftor) for Children and Adolescents With Cystic Fibrosis Between the Ages of 6 Months and 18 Years With the R117H Mutation in the CFTR Gene Vertex Pharmaceuticals Incorporated
11-Jun-2020 ICR and Cancer Research UK spinout company Monte Rosa Therapeutics launches with library of anti-cancer compounds Cancer Research UK
11-Jun-2020 RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib RedHill Biopharma
11-Jun-2020 Genmab and AbbVie Announce Broad Oncology Collaboration Genmab
11-Jun-2020 Pierre Fabre receives European Commission Marketing Authorisation for BRAFTOVI® (encorafenib) in combination with Erbitux® (cetuximab) for the treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC) who have received prior systemic therapy Pierre Fabre
11-Jun-2020 ERT Acquires APDM Wearable Technologies to Reinvent Endpoint Measurement in Clinical Trials ERT
11-Jun-2020 Ashvattha Therapeutics Subsidiary Orpheris Announces Completion of Phase 1 Study of OP-101 Subcutaneous Formulation Ashvattha Therapeutics
11-Jun-2020 Sanofi to present growth opportunities and development strategy for Dupixent® (dupilumab) in type 2 inflammatory diseases Dupixent